Patients with certain GLP1R or GIPR variants may experience robust appetite suppression at lower doses, while others may require higher doses for similar metabolic benefits
The glow peptide naming problem
Unfortunately, the MDS-UPDRS part 3 primary readout showed a strong placebo effect in the placebo group, and no difference to the drug group was seen
Several small studies suggest that dysautonomic syndromes, such as orthostatic hypotension, postural orthostatic tachycardia syndrome (POTS), and syncope are associated with vitamin B12 deficiency and may be improved by vitamin B12 therapy (33
Claims do not capture out-of-pocket GLP-1 use, which they note may cause the study to underestimate persistence
Horowitz M, ODonovan D, Jones KL, Feinle C, Rayner CK, Samsom M